Year Authors/Creators Item Type Full Text

2021

The cost-effectiveness of case-finding strategies for achieving hepatitis C elimination among men who have sex with men in the UK. (2021) Macgregor, Louis; Ward, Zoe; Martin, Natasha K; Nicholls, Jane; Desai, Monica; Hickson, Ford; Weatherburn, Peter; Hickman, Matthew; Vickerman, Peter

Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapy. (2021) Smith, David A; Bradshaw, Daniel; Mbisa, Jean L; Manso, Carmen F; Bibby, David F; Singer, Joshua B; Thomson, Emma C; da Silva Filipe, Ana; Aranday-Cortes, Elihu; Ansari, M Azim; Brown, Anthony; Hudson, Emma; Benselin, Jennifer; Healy, Brendan; Troke, Phil; McLauchlan, John; Barnes, Eleanor; Irving, William L

2019

Treatment and monitoring of children with chronic hepatitis C in the Pre-DAA era: A European survey of 38 paediatric specialists. (2019) Indolfi, Giuseppe; Bailey, Heather; Serranti, Daniele; Giaquinto, Carlo; Thorne, Claire; PENTAHep Study Group

Advanced liver disease in Russian children and adolescents with chronic hepatitis C. (2019) Turkova, Anna; Volynets, Galina V; Crichton, Siobhan; Skvortsova, Tamara A; Panfilova, Victoria N; Rogozina, Natalia V; Khavkin, Anatoly I; Tumanova, Elena L; Indolfi, Giuseppe; Thorne, Claire

2018

Understanding hepatitis C intervention success-Qualitative findings from the HepCATT study. (2018) Harris, M; Bonnington, O; Harrison, G; Hickman, M; Irving, W; HepCATT team

Patterns of mutation within an emerging endemic lineage of HEV-3a. (2018) Zhu, Yuan O; Aw, Pauline; Aung, Myo Myint; Lee, Hong Kai; Hibberd, Martin; Lee, Guan Huei

2017

Estimate of vertical transmission of Hepatitis C virus in Pakistan in 2007 and 2012 birth cohorts. (2017) Benova, Lenka; Awad, Susanne Faissal; Abu-Raddad, Laith Jamal

2016

Finding the undiagnosed: a qualitative exploration of hepatitis C diagnosis delay in the United Kingdom. (2016) Harris, M; Ward, E; Gore, C

2014

HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact. (2014) Martin, NK; Foster, GR; Vilar, J; Ryder, S; Cramp, ME; Gordon, F; Dillon, JF; Craine, N; Busse, H; Clements, A; Hutchinson, SJ; Ustianowski, A; Ramsay, M; Goldberg, DJ; Irving, W; Hope, V; De Angelis, D; Lyons, M; Vickerman, P; Hickman, M

2013

Assessing the cost-effectiveness of finding cases of hepatitis C infection in UK migrant populations and the value of further research. (2013) Miners, AH; Martin, NK; Ghosh, A; Hickman, M; Vickerman, P

2012

Hepatitis C infection among recent initiates to injecting in England 2000-2008: Is a national hepatitis C action plan making a difference? (2012) Hope, V; Parry, JV; Marongui, A; Ncube, F

2011

Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots. (2011) Hope, VD; Hickman, M; Ngui, SL; Jones, S; Telfer, M; Bizzarri, M; Ncube, F; Parry, JV

2010

Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa. (2010) Mendy, ME; Welzel, T; Lesi, OA; Hainaut, P; Hall, AJ; Kuniholm, MH; McConkey, S; Goedert, JJ; Kaye, S; Rowland-Jones, S; Whittle, H; Kirk, GD picture_as_pdf

2008

Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomized controlled trial. (2008) Hickman, M; McDonald, T; Judd, Ali; Nichols, T; Hope, V; Skidmore, S; Parry, JV

Hepatitis C in ethnic minority populations in England. (2008) Mann, AG; Trotter, CL; Balogun, M Adekoyejo; Ramsay, ME

The cost-effectiveness of screening and treatment for hepatitis C in prisons in England and Wales: a cost-utility analysis. (2008) Sutton, AJ; Edmunds, WJ; Sweeting, MJ; Gill, ON

A comparison between the force of infection estimates for blood-borne viruses in injecting drug user populations across the European Union: a modelling study. (2008) Sutton, AJ; Hope, VD; Mathei, C; Mravcik, V; Sebakova, H; Vallejo, F; Suligoi, B; Brugal, MT; Ncube, F; Wiessing, L; Kretzschmar, M

Response rates to combination therapy for chronic HCV infection in a clinical setting and derivation of probability tables for individual patient management. (2008) Thomson, BJ; Kwong, G; Ratib, S; Sweeting, M; Ryder, SD; De Angelis, D; Grieve, R; Irving, WL; Trent HCV Study Group

2007

Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004. (2007) Hickman, M; Hope, V; Brady, T; Madden, P; Jones, S; Honor, S; Holloway, G; Ncube, F; Parry, J

Hepatitis B vaccine uptake among injecting drug users in England 1998 to 2004: is the prison vaccination programme driving recent improvements? (2007) Hope, VD; Ncube, F; Hickman, M; Judd, A; Parry, JV

Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales? (2007) Judd, A; Hickman, M; Hope, VD; Sutton, AJ; Stimson, GV; Ramsay, ME; Gill, ON; Parry, JV

The burden of hepatitis C in England. (2007) Sweeting, MJ; De Angelis, D; Brant, LJ; Harris, HE; Mann, AG; Ramsay, ME

2005

Pathways of care and resource utilization in a national cohort of patients with transfusion-acquired hepatitis C. (2005) Brant, L; Harris, HE; Ramsay, ME; Grieve, R; Roberts, J; HCV National Register Steering Group*

Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis. (2005) Judd, A; Hutchinson, S; Wadd, S; Hickman, M; Taylor, A; Jones, S; Parry, JV; Cameron, S; Rhodes, T; Ahmed, S; Bird, S; Fox, R; Renton, A; Stimson, GV; Goldberg, D

2004

Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance. (2004) Yee, LJ; Kelleher, P; Goldin, RD; Marshall, S; Thomas, HC; Alberti, A; Chiaramonte, M; Braconier, J-H; Hall, AJ; Thursz, MR